...
首页> 外文期刊>Saudi Pharmaceutical Journal >Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systems
【24h】

Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systems

机译:不同类型的低取代羟丙基纤维素对漂浮药物递送系统的压片,崩解和漂浮行为的影响

获取原文

摘要

The object of the present study is to evaluate the effect of application of low-substituted hydroxypropyl cellulose (L-HPC) 11 and B1 as excipients promoting floating in gastroretentive tablets. Directly compressed tablets were formed based on experimental design. Face-centred central composite design was applied with two factors and 3 levels, where amount of sodium alginate (X"1) and L-HPC (X"2) were the numerical factors. Applied types of L-HPCs and their 1:1 mixture were included in a categorical factor (X"3). Studied parameters were floating lag time, floating time, floating force, swelling behaviour of tablets and dissolution of paracetamol, which was used as a model active substance. Due to their physical character, L-HPCs had different water uptake and flowability. Lower flowability and lower water uptake was observed after 60min at L-HPC 11 compared to L-HPC B1. Shorter floating times were detected at L-HPC 11 and L-HPC mixtures with 0.5% content of sodium alginate, whereas alginate was the only significant factor. Evaluating results of drug release and swelling studies on floating tablets revealed correlation, which can serve to help to understand the mechanism of action of L-HPCs in the field development of gastroretentive dosage forms.
机译:本研究的目的是评估应用低取代羟丙基纤维素(L-HPC)11和B1作为促进胃滞留片剂中漂浮的赋形剂的效果。基于实验设计形成直接压制的片剂。以面心为中心的中央复合材料设计应用了两个因素和三个层次,其中海藻酸钠(X“ 1)和L-HPC(X” 2)的数量是数值因素。 L-HPCs的应用类型及其1:1混合物包括在分类因子(X“ 3)中。研究参数为漂浮滞后时间,漂浮时间,漂浮力,片剂溶胀行为和扑热息痛的溶出度,将其用作L-HPC由于其物理特性而具有不同的吸水率和流动性,与L-HPC B1相比,L-HPC 11在60分钟后观察到较低的流动性和较低的吸水率。 -HPC 11和L-HPC混合物中海藻酸钠的含量为0.5%,而海藻酸钠是唯一的重要因素,对浮片的药物释放和溶胀研究的评估结果显示出相关性,可有助于理解HPC的作用机理。 L-HPC在胃滞留剂型领域的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号